Micro-RNAs in inflammatory arthritis: From physiopathology to diagnosis, prognosis and therapeutic opportunities
- 1 July 2019
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 165, 134-144
Abstract
No abstract availableKeywords
Funding Information
- Novartis Pharma
This publication has 92 references indexed in Scilit:
- Comprehensive microRNA Analysis Identifies miR-24 and miR-125a-5p as Plasma Biomarkers for Rheumatoid ArthritisPLOS ONE, 2013
- MiR-20a regulates ASK1 expression and TLR4-dependent cytokine release in rheumatoid fibroblast-like synoviocytesAnnals of the Rheumatic Diseases, 2013
- The miR-17 ∼ 92 Cluster: A Key Player in the Control of Inflammation during Rheumatoid ArthritisFrontiers in Immunology, 2013
- Discovering the first microRNA-targeted drugJournal of Cell Biology, 2012
- Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expressionAnnals of the Rheumatic Diseases, 2011
- The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritisArthritis & Rheumatism, 2011
- A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinomaJournal of Clinical Investigation, 2011
- Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus InfectionScience, 2010
- Synovial fibroblasts spread rheumatoid arthritis to unaffected jointsNature Medicine, 2009
- A microRNA polycistron as a potential human oncogeneNature, 2005